Alpha Cognition Inc (TSE:ACOG) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Alpha Cognition Inc., a biopharmaceutical firm focusing on neurodegenerative diseases, has announced the resignation of CFO Don Kalkofen and the interim appointment of Jay Yoo, an experienced CPA and CFA. The company has recently achieved significant milestones, including the approval of their Alzheimer’s treatment ZUNVEYL, and is preparing for its early 2025 launch.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.
